Asthma (bronchial asthma) is a chronic lung disease. Asthmatics suffer from seizure-related shortness of breath and coughing. One distinguishes between allergic and non-allergic asthma. With different medications and a customized lifestyle, the symptoms can be alleviated. Under certain conditions, asthma is even curable.
The number of asthmatics in Germany is increasing. Asthma is now one of the most significant chronic diseases. In particular, childhood asthma is common: about ten percent of all children suffer from bronchial asthma, boys more often than girls. By contrast, only about five percent of adults have asthma symptoms and women are more likely to be asthmatic than men.
Depending on the trigger, a distinction is made between allergic and non-allergic asthma. If the respiratory disease is due to an allergy, certain allergens trigger an asthma binge, such as pollen, house dust or mold. Often the disease then occurs together with other allergies and usually begins in childhood. In contrast, non-allergic asthma usually develops only in the course of life. There are also mixed forms of both disease types.
Typical asthma symptoms include nocturnal cough and shortness of breath. Such symptoms can persist while others use asthma symptoms suddenly and increase to an asthma attack.
In principle, asthma treatment consists of four pillars:
Asthma drugs (s.u.) to alleviate the symptoms and to get hold of asthma attacks, whereby the patient must learn to use his remedy reliably and properly, so that they can develop their full effect.
Avoiding asthma triggers (allergen avoidance and trigger avoidance).
A good asthma patient training and the implementation of the learned in daily life.
Check the course of the disease by the doctor (depending on severity, for example, every three months to check the symptoms, lung function, follow the treatment plan and then, if necessary, course-oriented adjustment of the treatment).
The asthma treatment is already possible at a price from €4,000. Please send us your inquiry with a current x-ray image to get a detailed estimate cost.
German Medical Group is a medical platform that does not represent interests of specific hospitals or doctors.
Our services do not affect the price for asthma treatment, you pay the bill right in the chosen clinic.
Submit a request on German Medical Group website - our manager will give you all the info regarding a particular doctor for asthma treatment or hospital. This consultation is FREE. Together we choose the best specialist for asthma treatment for your case. With German Medical Group you avoid waiting lists, get 24/7 support until your coming back home. Learn more about us here.
Follow these steps to choose the best doctor for asthma treatment:
Learn the info about doctors for asthma treatment listed below. It represents top specialists in Europe.
Submit a request on German Medical Group specifying the purpose of the treatment.
Our manager will call you back to book the chosen specialist for asthma treatment or offer another one according to the diagnosis, health condition, and financial ability.
If you approve the chosen doctor for asthma treatment, our manager schedules the date of your arrival.
Request for further information about Asthma Treatment using our Whatsapp and Viber number. +49 176 738 762 53
Our goal is to contact you within a business day to review your medical and financial information.
Between 2009 and 2016, the incidence of asthma in outpatient care increased by 35 percent, but only in adults. In children and adolescents, on the other hand, the proportion of patients receiving asthma remained largely constant over the observation period. This emerges from a new study in the supply atlas of the central institute for the Kassenärztliche supply in Germany (Zi).
The study also identifies differences between urban and rural regions. In large cities, the proportion of those insured for asthma was around 25 percent higher than in rural areas.
For the present evaluation, the researchers of the Supply Atlas have used nationwide contract medical billing data for the years 2009 to 2016. For the year 2016 alone, they have included more than 70 million billing data. Patients with asthma were identified according to the ICD-10 classification (code J45.- "bronchial asthma").
For the prevalence calculation, the scientists included those patients who had their asthma coded in at least two different quarters of a calendar year. The one-year diagnosis prevalence was determined as the proportion of asthma patients in all insured persons who had used contracted-care services at least once in each calendar year. According to this classification, the prevalence of asthma in 2016 was 5.9 percent in adults and 5.1 percent in children and adolescents.
In the observation period from 2009 (4.3 percent) to 2016 (5.9 percent), there was a significant increase in the prevalence of diagnoses in adults, while there was only a small increase in children and adolescents (4.9 percent in 2009 and 5.1 Percent 2016).